INS and obesity disorder: From a mechanistic perspective, obesity can drive oncogenesis through the decreased secretion of adiponectin and the chronic production of adipokines, insulin, insulin-like growth factor, inflammatory cytokines and tumour necrosis factor including IL-6 and TNFa.